An Insight Into New Drugs For Tics
Tic disorder is a chronicneuropsychiatric disorder that mostly occurs in children and adolescents. Theetiology and pathogenesis of the disease are still unclear, which may be causedby a combination of genetic, pathological, psychological and other factors. Themain manifestations are early symptoms (involuntary small movements, smallexpressions), motor tics (involuntary muscle twitches), vocal tics(uncontrolled complex vocalizations or Tourette), and psycho-behavioraldisorders (such as obsessive-compulsive behavior). Without timely intervention,the disease can be repeatedly protracted, seriously affecting the quality oflife of patients. Clinical treatment is mainly based on psycho-behavioraltherapy, supplemented by drug therapy, and timely intervention has a betterprognosis. Below are several new drugs for tics.
1. Xingnao Anshen tablets
Xingnao Anshen Tablet is a Chinesepatent medicine with less side effects. In addition, it also has the effect ofclearing away heat and detoxifying, and is used for hypertension, neurosis,insomnia, etc. In the treatment of tics, patients can use some drugs such asXingnao Anshen tablets, and their therapeutic effect is relatively good. Thisdrug can effectively relieve the phenomenon of excessive psychological pressureof the patient's friends, and can relax the patient's body and mind, andeffectively control the further development of the disease.
2. Phenytoin sodium tablets
Phenytoin is an antiepileptic andantiarrhythmic drug. Therapeutic doses do not cause sedative-hypnotic effects.This product has few side effects and is widely used. It is indicated for thetreatment of generalized tonic-cluster seizures, complex partial seizures(psychomotor seizures, temporal lobe epilepsy), simple partial seizures(localized seizures) and status epilepticus. When necessary, patients can alsochoose new drugs for tics that control nerves to treatment. Under normalcircumstances, they can choose to use some phenytoin tablets for treatment underthe guidance of doctors. This drug can help patients avoid the phenomenon ofexcessive mental stress, and also has a good therapeutic effect on thetreatment of tics.
3. Haloperidol tablets
Haloperidol tablets are thefirst-generation antipsychotic drugs, mainly used for the treatment of acuteand chronic schizophrenia, mania, Tourette's syndrome, and can also be used forcerebral organic mental disorders and senile mental disorders . It is mainlyaimed at hallucinations, delusions, and psychomotor excitement. It has feweradverse cardiovascular reactions. It is mostly the first choice in the acutephase of schizophrenia. The clinical effect is relatively fast. The main sideeffects are extrapyramidal side effects, such as Increased muscle tone, akathisia,and upturned eyelids. After the occurrence of tic disease, patients can alsochoose to use haloperidol tablets to adjust the disease, after takinghaloperidol tablets, can effectively alleviate the phenomenon of patients'inner pressure is too tense, can make people's spirit to be alleviated, caneffectively control the disease.
4. Diazepam
This product is a benzodiazepineanti-anxiety drug with anti-anxiety, sedative, hypnotic, anti-convulsant,anti-epileptic and central muscle relaxation effects. It is commonly used totreat anxiety, insomnia, muscle spasm and some epilepsy. Diazepam is also usedin several medical procedures (such as endoscopy) to reduce tension andanxiety, and in some surgical procedures to promote memory loss. Compared withbarbiturate hypnotics, it has a high therapeutic index, little effect onbreathing, little effect on fast-wave sleep, no effect on liver enzymes, and noanesthesia at high doses. It is the most commonly used hypnotic drug inclinical practice. Diazepam also has certain side effects, such as excessivesedation can cause drowsiness, hangover reaction, long-term use of diazepam canform drug dependence.
5. Thiapride
This product can be used as one ofthe first-choice new drugs for tics. It can enhance the effect of centraldepressants and can be used in combination with analgesics, hypnotics,tranquilizers, antidepressants, anti-tremor paralysis drugs and anti-epilepticdrugs, but at the beginning of treatment, the dose of co-administered centraldepressants should be reduced . The more common adverse reactions aredrowsiness (incidence is about 2.5%), galactorrhea, amenorrhea (returns tonormal after drug withdrawal), digestive tract reactions, dizziness, fatigue,etc. Some people may also experience excitement.
We all know that the treatment oftics requires a long-term process. Patients must use drugs for a long time.Long-term use of western medicine may often lead to abnormal liver and kidneyfunction in patients. In order to reduce the occurrence of other complicationsSymptoms, patients should be treated by a combination of traditional Chineseand Western medicine. Clinically, there are many new drugs for tics disorder.When treating, we must choose the appropriate treatment method, use drugsscientifically and rationally to relieve the condition, and at the same timeuse psychotherapy, so that In order to effectively control the furtherdevelopment of the disease.
Looking for chemical products? Let suppliers reach out to you!
2026-07-11
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Egyptian Pharmaceutical Market Research
-
CPHI China 2023 | At the Heart of Pharma
-
A Guide Into What the Pharmaceutical Use of Hexamine Is
-
In line with the 8201, Hengrui Pharmaceutical plans the HER2 ADC in this way
-
$50 billion in products were 'returned' to rationalize those blockbuster BD deals
-
Tronsound long-acting IL-36R antibody obtained FDA clinical IND
-
Dapagliflozin is approved in the EU for the treatment of symptomatic chronic heart failure
-
The FDA accepted Zuranolone's NDA application and granted it priority review rights for the treatment of MDD and PDD
-
Asia Hong Pharma announced that it has co-developed an innovative tumor therapy based on AI+RNA technology route with ReviR
-
Ribo Biologics announced that the world's first FIH application for a siRNA drug targeting FXI has been successfully approved by HREC in Australia
Recommend Reading
-
Applications of Caesium Iodide
-
Salinity Solution: Preparation and Uses
-
Rubber Cement: Applications and Safety Guidelines
-
Methylcellulose Uses: Food, Industrial Applications & Safety
-
Sodium Benzoate (E211): Safety, Benzene Risk, and Preservative Uses
-
FDA and NIH Launch a New Nutrition Science Partnership
-
FDA Reopens the Raw Manure Debate
-
5%–10% Is Just the Surface: Behind Dow’s Greater China Price Letter Lies a Global Repricing of Silicones
-
Premium Global Chemical Sourcing Requests (8-12 Dec 2025)
-
Geopolitical Costs Strongly Rise, PVC Spot Prices Surge in China